Home    Back

Allogeneic stem cell transplantation    (DrugBank: -)

2 diseases
IDDisease name (Link within this page)Number of trials
49Systemic lupus erythematosus2
84Sarcoidosis1

49. Systemic lupus erythematosus    [ 827 clinical trials,   638 drugs,   (DrugBank: 168 drugs),   108 drug target genes,   191 drug target pathways]
Searched query = "Systemic lupus erythematosus", "SLE"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 827 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00684255
(ClinicalTrials.gov)		August 200722/5/2008Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)Reduced Intensity Conditioning And Allogeneic Stem Cell Transplantation in Patients With Medically Refractory Systemic Lupus Erythematosus and Medically Refractory Systemic Sclerosis (SSc)Systemic Lupus Erythematosus;Systemic SclerosisProcedure: Reduced Intensity Allogeneic Transplant;Drug: Fludarabine;Drug: Busulfan;Drug: CampathNew York Medical CollegeNULLTerminated7 Years50 YearsAll1Phase 1United States
2NCT00278590
(ClinicalTrials.gov)		July 200416/1/2006Allogeneic Stem Cell Transplantation in Systemic Lupus ErythematosusAllogeneic Stem Cell Transplantation in Patients With Systemic Lupus ErythematosusSystemic Lupus ErythematosusBiological: Allogeneic Stem Cell TransplantationNorthwestern UniversityNULLWithdrawn18 Years50 YearsAll0Phase 1United States

84. Sarcoidosis    [ 143 clinical trials,   221 drugs,   (DrugBank: 79 drugs),   82 drug target genes,   165 drug target pathways]
Searched query = "Sarcoidosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 143 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00282438
(ClinicalTrials.gov)		December 200324/1/2006Hematopoietic Stem Cell Support in Patients With Refractory SarcoidosisHematopoietic Stem Cell Transplant in Patients With Refractory Sarcoidosis: A Phase I/II TrialSarcoidosisBiological: Autologous hematopoietic stem cell transplantation;Biological: Allogeneic stem cell transplantationNorthwestern UniversityNULLTerminated18 Years60 YearsAll2Phase 1;Phase 2United States